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Background:  After resection of long-segment 
Hirschsprung's disease, severe perianal dermatitis 
(SPAD) may occur because of high stool frequency and 
elevated concentrations of fecal pancreatic proteases. We 
investigated prospectively the effect of potato-derived 
protease inhibitors (PPI) on skin conditions in children 
with postoperative SPAD.
Methods: Four children (aged 12 to 24 months) 
with therapy-resistant SPAD after transanal endorectal 
pull-through for long-segment Hirschsprung's disease 
received topical PPI (1% in 20% zinc ointment) with 
each diaper-change. Parents noted down a subjective 
dermatitis score daily. Photo documentation and 
outpatient visits were made to assess the treatment 
results.
Results: No adverse effects were observed after 
treatment with PPI. A remarkable improvement of the 
dermatitis in 3 of the 4 patients as well as improvements 
in pain and sleep disorders were observed during the 
PPI-treatment course.
Conclusion: The results of the study suggest that PPI 
may reduce otherwise intractable protease-induced skin 
irritation in infants.
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Introduction
With long-segment Hirschsprung's disease, perianal skin excoriation is a common problem with any operative procedures 
applied[1-5] including transanal endorectal pull-through 
(TERPT).[6,7] The temporarily increased stool frequency 
during the early postoperative period[8,9] is probably due 
to intraoperative internal sphincter dilation,[10] which 
results in a condition termed pseudo-incontinence.
Feces contain proteases such as trypsin, alpha-
chymotrypsin and elastase which are secreted by the 
pancreas, the small intestinal brush-border and the 
stomach.[11] The activity of these proteases is normally 
neutralized during the transit along the small intestine 
and colon.[12,13] The proteolytic activity in feces is 
several times higher in newborns and infants than in 
adults.[14] Proteolytic activity is also increased with a 
reduced intestinal passage time (e.g., after colectomy), 
or with diarrhea when small bowel content reaches the 
perianal skin.[14]
In children with long-segment Hirschsprung's 
disease undergoing total or near-total colectomy and 
TERPT, three factors (rapid transit time,[15] no colonic 
enzyme inactivation,[13] high enzyme concentration due 
to infancy[14]) and probably intraoperative sphincter 
dilatation, even careful operative technique contribute 
to a high stool frequency and proteolytic activity in 
feces, predisposing them to perianal dermatitis.[13-15]
The most important fecal proteases (trypsin, 
α-chymotrypsin and elastase) can be inhibited by 
potato-derived protease inhibitors.[14] In infants with 
Hirschsprung's disease, this therapeutic concept has 
not yet been evaluated. We studied this novel protease 
inhibitor in four children with severe perianal dermatitis 
(after TERPT for long segment Hirschsprung's disease) 
refractory to all conventional treatments.
Methods
A prospective study was approved by the ethical 
committee of the Children's Hospital, Inselspital, 
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University of Bern. The parents of four children with 
perianal dermatitis after TERPT for long-segment 
Hirschsprung's disease gave informed consent to topical 
treatment with a potato-derived protease inhibitor (PPI). 
A trial with PPI was initiated if dermatitis persisted for 
more than 4 months after the pull-through. Prior to PPI 
administration, all four children were unsuccessfully 
treated for months with several ointments and systemic 
medication. For at least 4 weeks before participating in 
the study, all patients used the carrier zinc oxide ointment 
(Riccovitan® (patient 1) or Zincream Medinova® (patients 
2-4)) without PPI. Therefore, the skin condition at the 
beginning of the study represents a control status of 
identical treatment without PPI. The only parameter that 
changed during the study was the addition of PPI to the 
previously employed zinc oxide ointment.
After exclusion of a history of hypersensitive skin 
reactions, an irritation test on the left upper arm was 
carried out two days before starting the treatment on the 
perianal region. Parents of the patients were asked to 
apply the PPI with each diaper-change and to record the 
times of application. They also noted daily a subjective 
dermatitis score (0 point: healthy skin, 10 points: worst 
dermatitis observed). Photodocumentation was made 
with visits to the hospital before, during and at the end 
of the treatment.
In all 4 patients, an ostomy was initially made 
because of long distance aganglionosis. The operation 
with TERPT and ostomy take-down was performed in 
a second stage. Patient 1 was a 2-year-old boy suffering 
from Zuelzer-Wilson syndrome (aganglionosis until 
terminal ileum and dysganglionosis until mid-ileum) 
and received a total colectomy, resection of the terminal 
ileum, and an ileoanal anastomosis. PPI treatment was 
initiated 14.5 months after TERPT. Patient 2 was a 
boy aged 1.5 years with the colon resected from the 
right colonic fl exure to the rectum since aganglionosis 
extended into the transverse colon. PPI treatment was 
started 10.5 months after the pull-through. Patients 
3 and 4 were twin boys of 1 year old, suffering from 
familial Hirschsprung's disease. In both, aganglionosis 
extended to the transverse colon and a TERPT with an 
ascendo-rectostomy was performed. PPI treatment was 
started 4 months after the operation.
PPI was prepared from potatoes (Bintje) as 
described previously[14] resulting in a lyophilized 75% 
protein fraction that was tested for sterility. The potato 
protein-extract was added either to Riccovitan® (patient 
1) or to Zincream Medinova® (patients 2-4), at a 
concentration of 1% (w/w).
Results
PPI-ointment was simple to apply and no adverse 
Fig. 1. Time course of daily evaluation by dermatitis score and 
frequency of application per day during the treatment with potato 
derived protease inhibitor in the four patients.
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effects were observed either during the hypersensitivity 
testing on normal skin or in the affected perianal 
skin areas. The PPI-ointment was stored at 4°C in 
a household refrigerator. The dermatitis scores and 
application frequencies for patients 1-4 are shown in 
Fig. 1. The pre- and post-treatment photographs of each 
patient showing improvement of the dermatitis in 3 out 
of the 4 patients (Fig. 2).
In patient 1, an improvement was noted from score 
8 to score 3 during the first 7 days. After that, the score 
decreased to 2 on days 15 and 16. During this time the 
boy was asleep for ≥7 hours for 6 nights, whereas prior 
to the treatment, he woke his parents up to 10 times per 
night. At day 17, the score increased again. However, the 
mother reported that pain after passing stools decreased 
and that he slept for more than 7 hours for several nights.
In patient 2, the dermatitis score decreased from 8 
to 2 within 3 weeks. From day 24 to 27 a score of 5 was 
seen; thereafter, the score remained at 2. The parents 
reported that the child slept better at night.
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In patient 3, the score decreased from 7 to 2 during 
the first 17 days. From day 17 to day 36, the score 
remained at 2-3. On days 37 and 38, the boy suffered 
from diarrhea and the score reached 8 on day 39, then 
dropped again to 1-2 on days 51-54.
In patient 4, an improvement was seen during the 
first 5 days (from score 4 to 2), but then, deterioration to 
score 6 occurred on day 9, followed by an improvement 
to score 1 on day 19. After day 19, the score remained 
low.
Discussion
Perianal dermatitis is a common complication after 
TERPT,[6,7] particularly in infants with long-segment 
Hirschsprung's disease since they have several factors 
contributing to the development of dermatitis.
Firstly, even after resection of short segment 
Fig. 2. Photographs of perianal skin conditions in patients 1-4 before 
and after 3-10 weeks of potato derived protease inhibitor treatment.
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Hirschsprung's and TERPT, frequent bowel movements 
are usually observed for a period of 1-3 months.[8,9] This 
effect is, however, of temporary nature since sphincter 
strength was recently shown to recover completely by 
14 months after the operation.[10] Secondly, the already 
high activity of pancreatic proteolytic enzymes in feces 
of healthy infants increases further after a resection of 
the colon.[14] Thirdly, inside a diaper, feces and urine 
may have the following effects: fecal enzymes increase 
the permeability of the skin for bile salts, contributing 
to skin irritation,[16] urea itself leads to hyperhydration 
of the skin, making it more permeable and irritable, 
and fecal urease produces ammonia from urea, which 
increases the pH.[16] The elevated pH contributes to 
the activation of fecal lipases,[15] which attack the 
intercellular lipid lamellae of the stratum corneum. So 
far, no specific treatment for this unpleasant condition 
is available. There are numerous unspecific treatments 
such as zinc or titanium oxide creme, steroid or 
antimycotic ointments, frequent diaper changes and 
other conventional measures such as painting with 
gentian violet, bathing, or drying the skin with a hair-
dryer. Pharmacotherapy has been tried with oral 
antibiotics, antimycotics, and antiperistaltic drugs. 
However, none of these treatments, either alone or in 
combination, was effective.
The protease inhibitor selected for the current study 
is unique in its ability to inhibit all pancreatic proteases 
that are clinically important in this context.[14] However, 
its isolation is a time-consuming process, limiting 
the number of patients that can be treated in a pilot 
study. Adverse effects were neither seen during the 
hypersensitivity testing on normal skin nor in the 
affected perianal skin areas, and parents appreciated the 
use of a "natural" potato protein preparation.
A remarkable improvement in the skin condition of 
3 of the 4 children with long-segment Hirschsprung's 
disease after colon resection and TERPT was observed 
after administration of the PPI ointment for several 
weeks. In two patients (patients 3 and 4), this effect 
lasted beyond the application period. Besides the 
effects on dermatitis score, an improvement of sleep 
disturbance in patients 1 and 2 was observed. This 
effect was not quantified, except by the reduced 
frequency of PPI-applications documented at night. 
The reduced pain after defecation of the children was a 
source of relief for the parents.
To our knowledge this is the first clinical study 
on the topical application of PPI with a focus on the 
possible therapeutic effects. There are also other 
possible applications of PPI, such as common diaper 
rash in infants, dermatitis after colectomy for Crohn's 
disease or ulcerative colitis, and patients with intestinal 
resection and ileostomy. We conclude that a larger trial 
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of PPI in perianal dermatitis is justifi ed because of the 
potential beneficial effect and a low risk of adverse 
effects.
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